- Home
- WAI vs CLNN Comparison
WAI vs CLNN Comparison
Compare WAI & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAI
- CLNN
- Stock Information
- Founded
- WAI 2018
- CLNN 2012
- Country
- WAI China
- CLNN United States
- Employees
- WAI N/A
- CLNN N/A
- Industry
- WAI
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- WAI
- CLNN Health Care
- Exchange
- WAI NYSE
- CLNN Nasdaq
- Market Cap
- WAI 28.2M
- CLNN 26.1M
- IPO Year
- WAI 2023
- CLNN N/A
- Fundamental
- Price
- WAI $2.20
- CLNN $2.66
- Analyst Decision
- WAI
- CLNN Strong Buy
- Analyst Count
- WAI 0
- CLNN 5
- Target Price
- WAI N/A
- CLNN $40.00
- AVG Volume (30 Days)
- WAI 55.7K
- CLNN 74.4K
- Earning Date
- WAI 05-27-2025
- CLNN 05-07-2025
- Dividend Yield
- WAI N/A
- CLNN N/A
- EPS Growth
- WAI N/A
- CLNN N/A
- EPS
- WAI N/A
- CLNN N/A
- Revenue
- WAI $3,750,352.00
- CLNN $350,000.00
- Revenue This Year
- WAI N/A
- CLNN N/A
- Revenue Next Year
- WAI N/A
- CLNN $2,066.67
- P/E Ratio
- WAI N/A
- CLNN N/A
- Revenue Growth
- WAI N/A
- CLNN N/A
- 52 Week Low
- WAI $2.30
- CLNN $2.55
- 52 Week High
- WAI $20.00
- CLNN $9.20
- Technical
- Relative Strength Index (RSI)
- WAI N/A
- CLNN 37.77
- Support Level
- WAI N/A
- CLNN $2.91
- Resistance Level
- WAI N/A
- CLNN $2.90
- Average True Range (ATR)
- WAI 0.00
- CLNN 0.19
- MACD
- WAI 0.00
- CLNN 0.00
- Stochastic Oscillator
- WAI 0.00
- CLNN 18.33
About WAI TOP KINGWIN LTD
Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides a number of essential business services in China to young and emerging companies including corporate business training services, which mainly focus on advanced knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising, and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.